| 0.904 | 0.005 | 0.904 | Antiobesity | | |
| 0.783 | 0.001 | 0.783 | Orexin receptor antagonist | | |
| 0.722 | 0.001 | 0.722 | Orexin receptor 2 antagonist | | |
| 0.691 | 0.001 | 0.691 | Orexin receptor 1 antagonist | | |
| 0.477 | 0.014 | 0.477 | Anticonvulsant | | |
| 0.435 | 0.07 | 0.435 | Analgesic | | |
| 0.342 | 0.039 | 0.342 | HERG channel blocker | | |
| 0.343 | 0.056 | 0.343 | Nootropic | | |
| 0.311 | 0.046 | 0.311 | Potassium channel (Voltage-sensitive) blocker | | |
| 0.231 | 0.02 | 0.231 | Cyclin-dependent kinase 3 inhibitor | | |
| 0.164 | 0.004 | 0.164 | 5 Hydroxytryptamine 3A antagonist | | |
| 0.166 | 0.008 | 0.166 | 5 Hydroxytryptamine 3 antagonist | | |
| 0.231 | 0.076 | 0.231 | Potassium channel blocker | | |
| 0.175 | 0.04 | 0.175 | Neurotrophic factor | | |
| 0.1 | 0.015 | 0.1 | 5 Hydroxytryptamine 3 agonist | | |
| 0.113 | 0.039 | 0.113 | Acetylcholine agonist | | |
| 0.096 | 0.027 | 0.096 | Viral attachment inhibitor | | |
| 0.093 | 0.039 | 0.093 | Phosphodiesterase 3A inhibitor | | |
| 0.065 | 0.013 | 0.065 | Acetyl-CoA carboxylase inhibitor | | |
| 0.065 | 0.028 | 0.065 | Bcl-xL inhibitor | | |
| 0.047 | 0.012 | 0.047 | Potassium channel subfamily K member 3 blocker | | |
| 0.073 | 0.039 | 0.073 | Bcl2 antagonist | | |
| 0.087 | 0.054 | 0.087 | Acetylcholine M3 receptor agonist | | |
| 0.084 | 0.052 | 0.084 | Acetylcholine nicotinic agonist | | |
| 0.124 | 0.095 | 0.124 | CC chemokine 6 receptor antagonist | | |
| 0.128 | 0.099 | 0.128 | Cholinergic | | |
| 0.143 | 0.114 | 0.143 | Platelet adhesion inhibitor | | |
| 0.055 | 0.034 | 0.055 | Nicotinic receptor alpha7 subunit antagonist | | |
| 0.129 | 0.115 | 0.129 | Protein kinase (CK1) gamma 3 inhibitor | | |
| 0.052 | 0.04 | 0.052 | Nicotinic alpha7 receptor agonist | | |
| 0.044 | 0.032 | 0.044 | Neurokinin 3 antagonist | | |
| 0.021 | 0.011 | 0.021 | Acetyl-CoA carboxylase 1 inhibitor | | |
| 0.052 | 0.043 | 0.052 | Nicotinic neuronal receptor agonist | | |
| 0.027 | 0.02 | 0.027 | LFA antagonist | | |
| 0.046 | 0.041 | 0.046 | Nicotinic receptor alpha4 subunit antagonist | | |